Abstract:The objective of this study was to develop a stable drug delivery platform that is biocompatible, biodegradable and would provide sustained combinatorial drug release for the control of bone infection while simultaneously supporting bone tissue regeneration. Chitosan has been widely used in tissue engineering and in a variety of biomedical applications due to its eco‐friendly and biodegradable properties and it possesses a physiochemistry similar to the extracellular matrix of bone. However, the application of chitosan has been limited by its inherent mechanical weakness. Halloysite nanotubes (HNTs) are a naturally‐occurring aluminosilicate clay with a hollow tubular structure. HNTs are widely used as a bulk filler to materially reinforce a variety of polymer materials from bone cement to rubber. They have also been shown to be a potent nanocontainer for the sustained release of varied bioactive factors. In this study, chitosan and HNTs and chitosan and HNTs, doped with gentamicin and BMP‐2, were combined in different wt./wt. ratios and cross‐linked with tripolyphosphate. The biodegradability, mechanical properties, and surface structure of the hybrid nanocomposites were tested. The ability of the nanocomposites to control bacterial growth while supporting bone tissue formation was also evaluated. Gentamicin was selected as a model drug to evaluate the drug release capability of the chitosan‐HNTs nanocomposites and with release, its effectiveness against E. coli was analyzed through growth inhibition studies. Results indicate that the addition of HNTs to the chitosan hydrogel significantly improved the gels’ mechanical properties, permitting an extended period of drug release, and without a negative affect on drug efficacy. The coatings were capable of inhibiting bacterial growth and osteoblasts cultured on the hydrogel surfaces showed enhanced growth and functionality. Our doped clay/chitosan nanocomposite may overcome the limitations of traditional anti‐bacterial hydrogels and its ability to support bone tissue formation may enable its use in bone defect repair results from osteomyelitis. Support or Funding Information Funding for this project was provided by the Louisiana Governor's Biotechnology Initiative and Louisiana Board of Regents OPT‐IN program.

An Asymmetric Microfluidic/Chitosan Device for Sustained Drug Release in Guided Bone Regeneration Applications

A pH-Responsive Asymmetric Microfluidic/Chitosan Device for Drug Release in Infective Bone Defect Treatment

Anti‐Infective and Histogenic Bioscaffold for Bone Defect Repair

An Antimicrobial Peptide-Loaded Gelatin/Chitosan Nanofibrous Membrane Fabricated by Sequential Layer-by-Layer Electrospinning and Electrospraying Techniques

Multilayered nanocomposite membrane orchestrating targeted dual release strategies for enhanced guided bone regeneration

Multifunctional Modification of SIS Membrane with Chimeric Peptides to Promote Its Antibacterial, Osteogenic, and Healing‐Promoting Abilities for Applying to GBR

3D printing of bone scaffolds for treating infected mandible bone defects through adjustable dual-release of chlorhexidine and osteogenic peptide

A Janus Microsphere Delivery System Orchestrates Immunomodulation and Osteoinduction by Fine-tuning Release Profiles

Antibacterial sequential growth factor delivery from alginate/gelatin methacryloyl microspheres for bone regeneration

β-tricalcium phosphate/gelatin composite scaffolds incorporated with gentamycin-loaded chitosan microspheres for infected bone defect treatment

Guided Bone Regeneration with Tripolyphosphate Cross-Linked Asymmetric Chitosan Membrane.

Polymer–Mesoporous Silica Nanoparticle Core–Shell Nanofibers as a Dual-Drug-Delivery System for Guided Tissue Regeneration

Antisense yycF and BMP-2 co-delivery gelatin methacryloyl and carboxymethyl chitosan hydrogel composite for infective bone defects regeneration

Biomimetic nanofibrous hybrid hydrogel membranes with sustained growth factor release for guided bone regeneration

Antibacterial chitosan coating on nano-hydroxyapatite/polyamide66 porous bone scaffold for drug delivery

Construction of Self-defensive Antibacterial and Osteogenic AgNPs/Gentamicin Coatings with Chitosan As Nanovalves for Controlled Release

Strontium chondroitin sulfate/silk fibroin blend membrane containing microporous structure modulates macrophage responses for guided bone regeneration

Precise in-situ release of microRNA from an injectable hydrogel induces bone regeneration

Vancomycin- and Strontium-Loaded Microspheres with Multifunctional Activities Against Bacteria, in Angiogenesis, and in Osteogenesis for Enhancing Infected Bone Regeneration

A pH/ROS-responsive antioxidative and antimicrobial GelMA hydrogel for on-demand drug delivery and enhanced osteogenic differentiation in vitro

Preparation and characterisation of a gellan gum-based hydrogel enabling osteogenesis and inhibiting Enterococcus faecalis